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Abstract
In this article, we present an up-to-date overview of the potential biomedical applications of
sodium MRI in vivo. Sodium MRI is a subject of increasing interest in translational research
as it can give some direct and quantitative biochemical information on the tissue viability, cell
integrity and function, and therefore not only help the diagnosis but also the prognosis of dis-
eases and treatment outcomes. It has already been applied in vivo in most of human tissues,
such as brain for stroke or tumor detection and therapeutic response, in breast cancer, in artic-
ular cartilage, in muscle and in kidney, and it was shown in some studies that it could provide
very useful new information not available through standard proton MRI. However, this technique
is still very challenging due to the low detectable sodium signal in biological tissue with MRI and
hardware/software limitations of the clinical scanners. The article is divided in three parts: (1) the
role of sodium in biological tissues, (2) a short review on sodium magnetic resonance, and (3) a
review of some studies on sodium MRI on different organs/diseases to date.
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Introduction
Proton magnetic resonance imaging (MRI) can generate more than 30 different kinds of image
contrast (and still counting) which can give the physicians crucial information of the anatomy,
and sometimes function, of the organs under investigation. All organs and most of the known
diseases (if not all) can be studied with this imaging technique in order to assess their presence
and/or degree of possible harm to the body. However very often, the information from standard
MRI cannot provide direct biochemical information about the health of the tissues, such as cell
integrity and tissue viability, or predict possible outcomes from different treatments. Sodium MRI
could provide some of this complementary information in a quantitative and non-invasive manner.
Sodium, symbol 23Na, is a quadrupolar nucleus with spin 3/2 which yields the second
strongest nuclear magnetic resonance (NMR) signal among all nuclei present in biological tis-
sues, after proton 1H. The NMR sensitivity for sodium is 9.2% of the proton sensitivity and the
concentration in vivo is approximately 2000 times lower than the water proton concentration. As
a consequence, sodium MRI have a average signal-to-noise (SNR) ratio which is around 3000
to 20000 times lower than the proton MRI SNR (depending on organs). Due to the increase of
the available magnetic fields for MRI scanners (1.5T, 3T, 7T, 9.4T), hardware capabilities such
as high gradient strengths with high slew rates, and new double-tuned radiofrequency (RF) coils,
sodium MRI is now possible in a reasonable time (around 10 to 15 minutes) with a resolution of a
few millimeters and has already been applied in vivo in many human organs such as human brain
for tumor and stroke, cartilage, kidneys, heart, muscle or breast cancer, that will be described in
this review article. Sodium MRI is still a subject of investigation for assessing its medical utility
as a complement to proton MRI or other imaging modalities such as PET and CT, and determine
the new functional/biochemical that it can provide.
The goal of this review is to describe some potential biomedical applications of sodium MRI
in vivo and is divided in three parts:
1. The role of sodium in biological tissues.
2. A short review on sodium magnetic resonance physics.
3. An overview of some studies on sodium MRI on different organs/diseases to date.
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1 Sodium in Biological Tissues
1.1 Homeostasis
Sodium is a vital component of the human body. It is an important electrolyte that helps main-
tain the homeostasis of the organism through osmoregulation (maintain blood and body fluid
volume) and pH regulation [1]. It is also involved in the cell physiology through the transmem-
brane electrochemical gradient, in heart activity, in the transmission of nerve impulses and muscle
contractions through propagation of action potential in neurons and muscle cells via the sodium
channels. Sodium concentrations are therefore very sensitive to changes in metabolic state of
tissues and integrity of cell membranes. The intracellular volume fraction is around 80% of the
tissues with a sodium concentration of 10-15 mM (or mmol/L), and the extracellular volume frac-
tion (including the vascular compartment) is around 20%, with a sodium concentration of 140-150
mM. Cells in healthy tissues maintain this large sodium concentration gradient between the intra-
cellular and extracellular compartments across the cell membrane, and any impairment of energy
metabolism or insult to the cell membrane integrity leads to an increase on intracellular sodium
concentration. The sodium influx and outflux in cells can occur by several routes such as Na+
channels, Na+/Ca+ exchange (NCX), Na+/H+ exchange (NHE), Na+/bicarbonate (HCO3−) co-
transporter, Na+/K+ /2Cl− cotransporter, Na+/Mg+ exchange and most importantly through the
Na+/K+-ATPase [2].
1.2 Na+/K+-ATPase
The Na+/K+-ATPase (also called sodium-potassium pump, or just sodium pump) is present within
the membrane of every animal cell [3, 4]. It is a plasma membrane-associated protein complex
that is expressed in most eukaryotic cells and can be considered either as an enzyme (ATPase) or
as an ion transporter (the Na+-pump). Its main function is to maintain the sodium and potassium
gradients across the membrane, and therefore participates in the resting potential of the cell, by
pumping three intracellular sodium ions out of the cell and two extracellular potassium ions within
the cell (see Fig. 1.2.1).
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Figure 1.2.1: Schematics of the sodium-potassium pump
(Na+/K+-ATPase).
This ion transport is performed against the electrochemi-
cal Na+ and K+ gradients existing across the cell membrane
and therefore requires energy provided by adenosine triphos-
phate (ATP) hydrolysis. This high electrochemical gradient is
essential to protect the cell from bursting as a result of os-
motic swelling and also creates a potential that is used for
transmitting nerve impulses and for pumping ions (such as
protons, calcium, chloride, and phosphate) and metabolites
and nutrients across the cell membrane (such as glucose and
amino acids) or neurotransmitters (such as glutamate in as-
trocyte cells). ATPase activity and ion transport are intimately
linked and are two aspects of the same function. Regulation
of Na+/K+-ATPase therefore plays a key role in the etiology
of some pathological processes. For example, when the de-
mand for ATP exceeds its production, the ATP supply for the Na+/K+-ATPase will be insufficient
to maintain the low intracellular sodium concentration and thus an increase of intracellular sodium
concentration can be observed.
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2.1 Short History of Sodium NMR
The bar chart in Fig. 2.1.1 presents the distribution of publications on sodium NMR and MRI
over the years since the discovery of magnetic resonance in the 1940s [5,6]. Data was obtained
from a research in Google Scholar with the research key words “sodium” or “23Na” along with
“magnetic resonance” or “magnetic resonance imaging” or “MRI” or “NMR” in the publication title.
Figure 2.1.1: Publication statistics on sodium NMR and MRI. Data was
obtained from a research in Google Scholar with the research key words
“sodium” or “23Na” along with “magnetic resonance” or “magnetic reso-
nance imaging” or “MRI” or “NMR” in the publication title.
It is interesting to notice the peak of publications
in the period 1991-1995 for the combination of sodium
NMR (spectroscopy) and MRI, which then decreases
while the publications on sodium MRI alone continues
to increases since the early 1980s. A shift of interest
appears from sodium NMR spectroscopy to MRI, which
is probably due to the recent availability of scanners
with high fields and therefore the possibility of perform-
ing sodium MRI in vivo in reasonable times, opening to
new exciting research perspectives.
Briefly, biological tissues were already investigated
with sodium NMR spectroscopy in the early 1970s [7,8]
and with sodium MRI in the early 1980s [9–11], first on
animals in vivo and then on human brain [12] and hu-
man heart and abdomen [13]. Sodium MRI was there-
fore applied for brain tumor and ischemia detection in
the late 1980s [14]. The years 1990s will see an in-
crease of interest in sodium MRI, due to the increase
of the magnetic fields in scanners, improvements of electronics and RF coils, and new rapid se-
quences that allow to acquire sodium images in a few minutes with a reasonable resolution of a
few millimeters [15], or new contrasts such as triple quantum filtered images [16–18]. This trend
continued in the 2000s until today.
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2.2 Sodium NMR Properties
The sodium nucleus has a spin I = 3/2 and possesses a quadrupolar moment Q which inter-
acts with the electric field gradients (EFG) generated by the electronic distribution around the
nucleus. In general, sodium in solids experience quadrupolar interactions while in liquids, the
static quadrupolar interaction is averaged to zero. In the intermediate regimes, e.g. in biological
tissues, the quadrupolar interaction results in a biexponential relaxation behavior. The dominance
of quadrupolar relaxation mechanism for NMR signals can allow a sensitive characterization of
the molecular environment of the sodium ions. A short T2 component T2short = 0.5-5 ms generally
contributes to 60% of the signal in living tissue and a long component T2long = 15-30 ms corre-
sponds to 40% of the signal. In order to detect both T2 components, imaging techniques with
ultrashort echo time (UTE) of less than 0.5 ms are required. But it is difficult to obtain reliable in-
formation about the biexponential relaxation from these conventional simple single-pulse / single
quantum (SQ) NMR methods. It has been shown that in the presence of biexponential relaxation,
multiple quantum coherences (MQC) can be created and detected with MQF sequences [19],
and thus give information about the interaction of sodium ions with their environment. Ranges of
sodium concentrations and relaxation times in some human tissues in vivo are given in Table 2.1
Table 2.1: Range of sodium concentrations and relaxation times in some human tissues in vivo.
Tissue [Na+] (mM) T1 (ms) T2short (ms) T2long (ms)
Brain WM 20-60 15-35 0.8-3 15-30
GM 30-70 15-35 0.8-3 15-30
CSF 140-150 50-55 - 55-65
Cartilage 250-350 15-25 0.5-2.5 10-30
Blood 140-150 20-40 2-3 12-20
Muscle 15-30 12-25 1.5-2.5 15-30
2.3 Tensors and Hamiltonians
Irreducible Spherical Tensor Operator (ISTO)
A convenient way to describe the various processes occurring during the pulse sequence is by the
irreducible spherical tensor operator (ISTO) basis [20–22], Tnm, where n is the rank andm is the
order (or coherence) of the tensor with |m| < n. These tensors are composed of combinations
of the more familiar spin operators Iz and I± = Ix± iIy. The ISTO used to describe the density
operator and the Hamiltonians for a spin 3/2 are given in Table 2.2. In order to follow the sequence
of events at high magnetic fields, one should bear in mind two simple rules:
12
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1. A non-selective radiofrequency (RF) pulse can change the coherence m within the limits
of |m| < n.
2. Changes in the rank n can occur by relaxation and modulation by quadrupolar, dipolar or
J-coupling, keeping the same value of m.
In the following sections, we consider that the spin system evolves only under the influence of
Zeeman, quadrupolar and RF Hamiltonians [22,23].
Table 2.2: Irreducible spherical tensor operators (ISTO) for spin I = 3/2.
ISTO Value Definition
T00 1 Identity
T10 Iz Longitudinal magnetization
T1±1 ∓ 1√2I± Rank 1 SQC
T20
1√
6
(
3I2z − I (I + 1)
)
Quadrupolar magnetization
T2±1 ∓ 12 [Iz, I±]+ Rank 2 SQC
T2±2 12I
2
± Rank 2 DQC
T30
1√
10
(
5I3z − (3I (I + 1)− 1) Iz
)
Octopolar magnetization
T3±1 ∓ 14
√
3
10
[
5I3z − I (I + 1)− 12 , I±
]
+
Rank 3 SQC
T3±2
√
3
4
[
Iz, I
2
±
]
+
Rank 3 DQC
T3±3 ∓ 12√2I3± Rank 3 TQC
SQC, DQC and TQC are respectively the single, double and triple quantum coherences.
The anticommutator for the operators A and B is defined as [A,B]+ = AB +BA.
Zeeman Hamiltonian (Hz)
The Zeeman Hamiltonian is given by
Hz = ω0T10, (2.3.1)
with ω0 = γNaB0 the Larmor angular frequency, γNa = 70.808493 × 106 rad · T−1 · s−1 the
sodium gyromagnetic ratio (26% of the proton γp) and B0 the magnetic field.
All the following Hamiltonians are expressed in the Larmor frequency rotating frame, in which this
Hz vanishes.
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Quadrupolar Hamiltonian (HQ)
Electric field gradient (EFG)
The nuclear quadrupole interaction is determined by the orientation, magnitude and temporal du-
ration of EFG generated by the electronic configuration of the molecular environment surrounding
the nucleus. If V (x, y, z) is the electrostatic potential produced by electrons at the point (x,y,z),
EFG can be described by the tensor Vαβ with the components:
Vαβ =
∂2V
∂α∂β
, (withα, β = x, y, z). (2.3.2)
If we choose the principal axes of the symmetric tensor Vαβ as coordinates axes, the cross-
terms vanish, i.e. Vxy = Vxz = Vyz = 0. It is common to label the remaining components
such that |Vzz| ≥ |Vyy| ≥ |Vxx|, and to define Vzz = eq (e is the unit electric charge) and the
anisotropy parameter:
η =
Vxx − Vyy
Vzz
, 0 ≤ η ≤ 1. (2.3.3)
Quadrupolar Hamiltonian
The quadrupolar interaction of the 23Na spin with the EFG is represented by the quadrupolar
Hamiltonian HQ. In the principal axis system (PAS) of Vαβ , it reads:
HQ = ωQ
2∑
m=−2
(−1)m F2,−mT2m, (2.3.4)
with the PAS spatial tensor components:
F2,0 =
√
3
2 ,
F2,±1 = 0,
F2,±2 = η2 ,
(2.3.5)
and the quadrupolar angular frequency:
ωQ =
e2qQ
6~
. (2.3.6)
Radiofrequency Hamiltonian (HRF )
If the RF pulse is applied on-resonance along the x-axis with field strength ωRF (t) = γNaB1 (t),
with B1 (t) the RF magnetic field, the corresponding RF Hamiltonian is time-dependent and
14
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reads:
HRF = ωRF Ix = ωRF
1√
2
(T1−1 − T1+1) . (2.3.7)
Total Hamiltonian (H)
In the Larmor rotating frame, the total Hamiltonian is then:
H = HRF +HQ. (2.3.8)
2.4 Quadrupolar Relaxation and NMR Spectra
Depending on the motional regime of the system, the energy levels of the system and the re-
laxation rates can be modified, giving one or many NMR peaks in the one-pulse single quantum
(SQ) 23Na spectra, as shown on Fig. 2.4.1 [24]. The following three motional regimes and four
different types of spectra are possible, depending on the nature of the spin dynamics and the
nature of the molecular environment [24–27]. In the following section, we consider that the Na+
ions are present in a single compartment with a single rotational correlation time τc. We also con-
sider that the system is in the Redfield regime, where the relaxation of spin 3/2 is described by
second-order perturbation theory, and where the spin dynamics can be solved analytically [22].
Isotropic Motion With Motional Narrowing (ω0τc  1)
In a system of rapid motion such as a fluid, all orientations of the EFG are equally probable. In this
isotropic system, the quadrupolar interaction is averaged to zero on the time scale of 2pi/ω0 and
the four energy levels of the spin 3/2 are equally distant by the angular frequency ω0. The 23Na
spectrum is then composed of a single resonance line at ω0, as shown in the type-d spectrum
in Fig. 2.4.1. Both transverse and longitudinal relaxations are simple exponential decays. The
liquid-like type-d spectrum was obtained from NaCl in aqueous solution.
Isotropic Motion Without Motional Narrowing (ω0τc ∼ 1)
In tissues where the macromolecular motion associated with the nucleus is isotropic but of the
same order of the Larmor frequency, the quadrupolar interaction dominates the relaxation. The
satellite and central transitions have different transverse relaxation rates R(±1)1 and R
(±1)
2 re-
spectively, and are dynamically shifted from the Larmor frequency with shifts K1 and K2 −K1,
respectively. However, these shifts are much smaller than the linewidths and very difficult to de-
tect. This situation can correspond to a biological-like type-c spectrum in Fig. 2.4.1, which was
15
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Figure 2.4.1: Typical energy levels and corresponding NMR spectra of sodium nuclei in different environments. Four
types of motionally narrowed SQ spectra are possible (a, b, c, and d). The type-a (crystal-like) and type-b (powder-
like) spectra are of Na+ in aqueous suspensions of oriented and unoriented dodecyl sulfate micelles, respectively. The
type-c (homogeneous, biexponential, super-lorentzian-like) spectrum is that of Na+ in an aqueous solution that has a
high concentration of micelle-solubilized gramicidin channels. The type-d (liquid-like) spectrum is that of NaCl in H2O.
From Rooney W. et al. NMR in Biomedicine 4, 209-226, 1991. Reproduced by permission of Wiley-Blackwell.
obtained from solubilized micelles in an aqueous solution. It is a “homogeneous” (“biexponen-
tial”, “super-Lorentzian”) spectrum, in which the satellite peaks have essentially coalesced into a
single, broad, homogeneous peak. The relaxation rates are:
R
(±1)
1 = Jo + J1 ± iK1,
R
(±1)
2 = J1 + J2 ∓ i (K1 −K2)
(2.4.1)
with the spectral densities (with m = 0, 1, 2):
Jm (mω) =
(2pi)2
20
(
χ2τc
1+(mω)2τ2c
)
,
Km (mω) = ωτcJm (mω) .
(2.4.2)
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The spectral densities Jm and Km are the real and imaginary parts of the FFT of the EFG
correlation function and χ is the root mean square coupling constant. Even in the absence of any
quadrupolar splitting, biexponential relaxation can create MQC which can be detected by triple
quantum filtering (TQF).
Anisotropic Motion (ω0τc > 1)
The sodium nuclei experiment non-averaged EFG and therefore a residual quadrupolar interac-
tion (RQI). The SQ relaxation rates are:
R
(1)
1 = J0 + J1 + J2 −
√
J22 − ω2Q,
R
(1)
2 = J1 + J2,
R
(1)
3 = J0 + J1 + J2 +
√
J22 − ω2Q.
(2.4.3)
Depending on the magnitude of J2, three situations can occur:
1. If ωQ < J2, the relaxation rates are real and there is no line splitting despite the presence
of RQI. The SQ spectrum is a sum of three Lorentzians. The RQI influences the linewidths
and amplitudes of the components, there is a very small splitting in the spectrum, but it is
masked by the larger SQ linewidths. This case can be still described by a type-c spectrum
in Fig. 2.4.1. In this case, the Double Quantum filter (DQF) signal due to even rank
coherence T2±2 can be used to detect and measure ωQ.
2. If ωQ > J2, the relaxation eigenvalues and corresponding to outer transitions are complex
and the satellite transitions are shifted by ±
√
ω2Q − J22 from the central line. This case
corresponds to a powder-like type-b spectrum in Fig. 2.4.1, which was acquired from
unoriented micelles in aqueous solution (unoriented liquid crystal). The DQF signal from
T2±2 can also be used to measure ωQ.
3. If ωQ  J2, the energy levels are all shifted by the RQI resulting in three distinct peaks
in the spectrum. The central transition and the two satellite transitions are separated by
ωQ. This frequency separation between the lines provides therefore indirect information
about RQI and the magnitude of ordering in the system. This case can be described by
a crystal-like type-a spectrum in Fig. 2.4.1, which was obtained from oriented micelles in
aqueous solution (oriented liquid crystal). Relative areas of the peaks are 3:4:3.
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2.5 Spectra Models
In tissue, Na+ aquo cations exist in compartmentalized spaces (intra- and extracellular compart-
ments for example) and encounter an abundance of charged macromolecules. The nature of
tissue is such that most of the sodium spectra are likely to be of type c or type b, or intermediate
or superpositions of these. Several models were therefore developed in order to understand the
SQ sodium spectra in biological tissues and are described in more details in Ref. [24,26,28] and
references herein.
Debye Model (DM)
The DM is the simplest model for the quadrupolar relaxation mechanism and is based on the
assumption that the random fluctuation of the EFG tensor strength and orientation that can be
described with a single correlation time, τc. This is the model that was used to describe the
spectra in the previous section (quadrupolar relaxation), assuming that the sodium ions are all
in a single environmental compartment and that no exchange between compartments occurs.
However, this model is too simple to describe sodium spectra in even simple biological tissues
such as bovine serum albumin in saline solution or suspensions of yeast cells.
Discrete Exchange Model (DEM)
The DEM is a more complex model based on equilibrium chemical exchange between distinct
sites that have different quadrupolar properties. These individual sites can be each character-
ized by a Debye model (single τc). For example, the James-Noggle exchange occurs between
two different type-d sites and can yield only a resultant type-d spectrum. Bull exchange happens
between a type-d site and a type-c site and can yield either type of resultant spectrum, depend-
ing on the lability of the exchange on the timescale determined by the properties of the two sites.
Chan exchange occurs between a type-d site and a type-a site and can produce all kinds of re-
sultant spectra, depending on the lability of the exchange or the random orientation distribution of
the type-a sites. However, a two-site DEM model has at least six (or even eight, if temperature is
included) independent parameters to describe the resultants spectra, and a three-site exchange
model requires at least 13 independent parameters. Analyzing the tissue situation with a realistic
DEM is therefore very difficult.
Berendsen-Edzes Model (BEM)
The BEM seems is a more realistic model which focuses on the EFG tensor projection fluctuations
caused by motions of the inner hydration shell of the ion Na+(aq), that are very powerful and very
18
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rapid. Slower modulations also occur, usually of lower amplitudes, and are generated as the aquo
ion diffuses and encounters macromolecules. The BEM mechanism is based on the concept of a
sample domain, as experienced by a diffusing aquo ions, which must be at least as large as the
average volume sampled by the diffusional excursions during the lifetime of an NMR coherence.
The BEM can therefore be useful for describing spectra by modeling domains with the same
(type-a) or random (type-b) orientations. A type-c spectrum can also be described using BEM,
for Na+ in the blood plasma for example, where rapid modulations of the inner hydration sphere
domain happen altogether with isotropic slow fluctuations of the EFG by diffusion. But this model
is still very difficult to interpret in complex biological tissues.
Other Models
Some other more complex models such as continuous diffusion models, models with distributions
of τc values, or Debye models with a distribution of ωQ values were also developed in order to
describe more accurately sodium spectra in biological tissues.
Rooney-Springer Protocol
In order to really have a accurate understanding of the sodium NMR data acquisitions in biological
tissues, Rooney and Springer [24] proposed a protocol in five steps. Although their complete
realization is very difficult, if not impossible, it is still important to consider them and to try to
complete at least some of them in order to have a good approximate understanding of the results
we obtain from sodium NMR spectroscopy or MRI in vivo:
1. Discriminate the SQ resonances from as many physiological compartments as possible.
2. Discriminate the spectral type (a, b, c or d) of each resonance.
3. Determine the numbers of magnetically distinct populations in slow exchange for each
resonance (the type of which has been determined above).
4. Measure as many relaxation times values as possible for each population.
5. Interpret the measured relaxation times values.
2.6 Multiple Quantum Filters (MQF)
In order to detect MQC from different types of spectrum and therefore obtain some information
about the biological environment of the sodium nuclei, MQF can be implemented before the NMR
acquisitions [19, 29–31]. MQF are described in Fig. 4. For all MQF experiments, the RF pulses
were considered as hard pulses (ωRF  ωQ).
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A first RF pulse of angle θ1 and phase φ1 is applied to the system to flip the longitudinal
magnetization T10 into the transverse plane, giving a transverse magnetization T1±1. During
the preparation time τ , the transverse magnetization T1±1 evolves in the presence of relaxation
and/or RQI, creating single quantum coherences (SQC) with different rank T1±1, T2±1, T3±1.
Figure 2.6.1: Multiple quantum filters (MQF) and coherence order trans-
fers. For triple quantum filter (TQF) with six-phase cycling, θ1 = θ2 =
θ3 = 90
◦, φ1 = 30◦, 90◦, 150◦, 210◦, 270◦, 300◦, φ2 = φ1 + 90◦,
φ3 = 0
◦. For double quantum filter (DQF) with four-phase cycling,
θ1 = θ2 = θ3 = 90
◦ , φ1 = 0◦, 90◦, 180◦, 270◦, φ2 = φ1, φ3 = 0◦.
For DQF with magic angle (DQF-MA), θ1 = 90◦, θ2 = θ3 = 54.7◦ ,
and the phase cycling is the same as for DQF. For all filters, the receiver
phase alternates between 0◦ and 180◦ .
In isotropic liquids only odd rank tensors T3±1 can be
formed during τ under the influence of quadrupolar re-
laxation. In anisotropic media, where the RQI does not
average to zero, rank tensors T2±1 can be also formed.
A second pulse θ2 and phase φ2 converts these
SQC into multiple quantum coherences (MQC) T1±1,
T2±2, T3±2, T3±3. During the evolution time δ, the
MQCs evolve with their characteristic relaxation times.
Generally, the evolution time δ is kept very short to
avoid their decay.
Since the MQCs cannot be detected directly, the fi-
nal RF pulse θ3 and phase φ3 converts the MQCs into
SQCs T1±1, T2±1, T3±1, which then evolve under re-
laxation and RQI to the detectable SQC T1±1 during
the acquisition time tacq. It can be notice that in gen-
eral, a 180◦ RF pulse can be applied in the middle of
the preparation time τ in order to refocus the chemical
shifts and magnetic field inhomogeneities. However, as
MQF are very sensitive to RF imperfections, it has been shown that filters without this refocusing
pulse generate a better signal and are more robust to RF inhomogeneities for MQF MRI [32].
The formation of DQC and TQC is detected separately by choosing the appropriate RF pulse flip
angles and phase cycling. The phase cycling and choice of RF pulses are given in the caption of
Fig. 2.6.1. DQF can detect the contribution of two tensors, T2±1, T3±1, due to the slow motion
regime or/and RQI in anisotropic media. if θ1 = θ2 = θ3 = 90◦, contributions from both T2±1
and T3±1 can be detected. If θ1 = 90◦ and θ2 = θ3 = 54.7◦ (magic angle), only the contribution
of T2±1 is detected, which arises only from the anisotropic RQI. Only T3±1 due to the slow motion
regime can be detected by the TQF sequence.
2.7 Fluid and Extracellular Sodium Suppression
In many diseases, a sodium concentration increases is detected, which can be caused by either
an increase of intracellular sodium concentration, increase of extracellular volume with a constant
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concentration (140 mM) or increase of vascularization. It is widely believed that the most sensi-
tive way to study the health of tissues in vivo should be done by isolating the sodium NMR signal
from the intracellular compartment. Intracellular sodium concentration and relaxation properties
should give access to some more useful information on the cells viability (homeostasis, ener-
getic state and sodium pump function) [33]. Four different techniques have been suggested to
suppress extracellular sodium and/or the signal from fluids around the tissue of interest.
Shift Reagents (SR)
This technique is based on the use a 23Na chemical shift reagent based on lanthanide chelates
as Tm(DOTP)5−, Dy(PPP)7−2 or Dy(TTHA)
3− [34–36]. These compounds do not penetrate the
cell membrane and therefore create a frequency offset for the sodium nuclei in the extracellular
space. But as they don’t cross the blood-brain barrier and because of their moderate toxicity,
these SR can’t be used in humans.
Diffusion
Diffusion-based techniques can separate the sodium signal from the intracellular and extracellular
compartments based on the differences between the motional properties of the ions in these
two compartments [37]. However, the fast T2 relaxation of sodium and its low gyromagnetic
ratio require the use of very large magnetic field gradients, which can cannot to be effectively
implemented in clinical MRI scanners.
Inversion Recovery (IR)
The IR technique is based on the difference in the T1 relaxation of the sodium nuclei in different
compartments. As the T1 relaxation time of the extracellular sodium or in fluid can be significantly
longer than the T1 of the intracellular sodium, IR can be used to eliminate the signal contribution
from either environment [38–40].
Multiple Quantum Filters
The MQF technique is based on the different T2 relaxation properties of the sodium nuclei in
the intracellular and extracellular or fluid compartments. MQF can be used to differentiate these
compartments, as they use coherence transfer schemes to generate an NMR signal that is related
to the presence of biexponential relaxation. The MQF are described in the previous section.
Depending on the pulse amplitudes and the phase cycling, these filters can allow the signal
coming from the sodium DQC or TQC to be read by the sequence. However, the signal intensity
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following a MQF sequence is a small fraction of the signal intensity following a single ideal 90◦
excitation pulse (around 10% has been given as a typical in vivo value).
Several reports estimate that the MQF NMR signal in biological tissues comes primarily from
the intracellular sodium [41–44], but this statement is still controversial and studies on physio-
logical samples have shown a significant contribution of the extracellular sodium in MQ-filtered
spectra [33,45,46].
Applications to Sodium MRI
IR and the MQF are the two only techniques that can be currently applied in sodium MRI in
vivo. Despite the fact that they cannot really separate completely the different compartments in
biological tissues, due to their complex distribution of spectrum types and relaxation times (see
Fig. 2.4.1), the resulting signals detected after application of these filters can still contain more
signal weighting from certain compartments (intracellular) compared to the others (extracellular,
fluid) and thus give some new useful information on the health of the tissue under study.
2.8 RF Pulse Sequences
Due to the short (biexponential) T2 relaxation of sodium in vivo, ultrashort TE (UTE) sequences
are recommended to acquire the images. The first sodium images were acquired with 3D gradient
Figure 2.8.1: K-space trajectories from UTE se-
quences. A. 3D radial. B. Twisted projection
imaging (TPI) or 3D cones types of sequences.
echo sequences [47] where the TE was minimized by using non-selective
hard pulse, in order to avoid using a slice refocusing gradient, and by ap-
plying read and phase gradients with the maximum slew rates and magni-
tudes. TE of the order of 2-3 ms can be obtained with this method. The
shortest TEs (< 1 ms) can generally be obtained by acquiring the data from
the center of the k-space in a radial or spiral fashion. The most common
type of this kind of sequence is the 3D radial sequence which has been
used widely for sodium MRI [48]. This method can then be improved from
the signal-to-noise ratio (SNR) and time efficiency point of view by mod-
ifying the density of acquisition points along the projections and also by
twisting the radial projection in the outer k-space in an optimal manner in
order to fill the k-space more homogeneously and improving the point spread function of the
acquisition method. This is done in sequences such as density adapted radial sequence [49],
twisted projection imaging (TPI) and its variations [15, 50, 51], 3D cones [52] or FLORET [53].
Examples of k-space trajectories from 3D radial and TPI sequences are shown in Fig. 2.8.1.
These latter sequences are now the standard for sodium MRI. Other UTE sequences have also
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been developed with even shorter TEs, but are still under investigation for about their application
to in vivo sodium MRI: SPRITE [54, 55], SWIFT [56], ZTE [57], PETRA [58]. The data acquired
with all these non-Cartesian sequences are then reconstructed using different methods, such
regridding [59–61] or non-uniform fast Fourier transform (NUFFT) algorithms [62,63], or iterative
methods [64,65].
2.9 Sodium Quantification
Sodium concentration quantification is generally performed by placing phantoms of known sodium
concentration and known relaxation times within the field-of-view of the images. It is better to use
phantoms with relaxation times that match approximately the relaxation times of the investigated
tissue in order to reduce uncertainties in the quantification. A linear regression from the phantom
signals, corrected for relaxation, is then used to produce the tissue sodium concentration (TSC)
map. For example, reference phantoms for brain or muscle imaging are composed of 2-3% agar
gels with sodium concentrations within the range of TSC usually found in these tissues (10 mM
up to 150 mM). For cartilage, 4-6% agar gels can be used, with sodium concentration between
100 to 350 mM.
2.10 Limitations and Prospects
Limitations
The low sodium concentration in biological tissues compared to the water concentration, associ-
ated with a low NMR sensitivity and very short transverse relaxation times, make the detection of
sodium signal quite challenging and result in images with low SNR (around 20-40), low resolution
(2-10 mm) and long acquisition times (10-30 min). Moreover, due the low gyromagnetic ratio of
the sodium nuclei (26% of proton gyromagnetic ratio), high magnetic field gradients need to be
used for acquiring images with higher resolution, which can therefore be limited by the hardware
capacities of the clinical scanners (around 40 mT/m in general). This gradient limitation can also
impede studies on sodium ions diffusion with MRI due to the very high gradients needed for
detecting even small ion displacements.
Other limitations include the need of high static magnetic fields (>3T) for increasing the
sodium signal associated with multinuclear capabilities and the availability of single tuned 23Na
coils or dual-tuned 1H /23Na RF coils that allow to acquire co-registered proton and sodium
images.
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Prospects
Sodium MRI acquisitions could profit from new recent multichannel capabilities developed for
rapid proton MRI with parallel data acquisition using array coils and parallel reconstruction algo-
rithms [66], and also new reconstruction schemes such as compressed sensing (CS), that allow
rapid undersampled data acquisitions [67]. A optimized combination of parallel-CS-NUFFT re-
construction associated with optimized sequences such as TPI at high field could therefore allow
to significantly reduce the acquisition time to a few minutes and still generate images of good
resolution (1-2 mm) and reasonable SNR, that would put sodium MRI in the realm of practical
clinical imaging techniques.
As assessing the intracellular sodium content can give more useful metabolic information on
the integrity of cells, techniques that increase the sensitivity of sodium MRI to this concentration.
such as IR or TQF, still need to be improved, in order to increase the SNR, and thus reduce the
resolution and acquisition time, of the images, as well as reducing their sensitivities to magnetic
field and RF inhomogeneities [68]. A recent new method based on optimal control theory [69,70]
could also prove to be useful for this purpose, but it is still under investigation and has not been
applied to in vivo sodium MRI yet.
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In this part we will give an overview of the possible biomedical applications of sodium MRI for
assessing diseases and therapies non-invasively and quantitatively in vivo. Of course, this list of
applications is not exhaustive, but we expect it shows a fair spectrum of the research that has
been performed over the last 30 years on this subject.
3.1 Brain
Since the first experiments on sodium MRI, many studies have been performed on brain, first
to show the feasibility of quantitative brain sodium MRI, and then to evaluate its possible use for
assessing diseases such as tumors, strokes, multiple sclerosis (MS), Alzheimer’s disease (AD) or
Huntington’s disease (HD), which will be described in this section. The hypothesis is that sodium
MRI could provide direct non-invasive information on the changes in cellular integrity/viability
through changes in intracellular sodium concentration and/or extracellular volume due to these
pathologies, and complement proton MRI or other imaging modalities [12, 14, 71–74]. Examples
of SQ and TQF brain sodium images are shown in Fig. 3.1.1 A-B. Some other examples of sodium
images with new TQF schemes can be found in Ref. [68,75,76] and with IR in Ref. [38,77].
Thulborn et al. [78] proposed to measure tissue sodium concentration (TSC) and cell vol-
ume fraction (CVF) for assessing diseased tissues in the brain (tumor, stroke), along proton MRI.
These two parameters are termed "bioscales", as they are quantitative parameters with spatial
distribution, while "biomarkers" are often just binary indicators of the presence of disease or not.
TSC is the volume fraction weighted mean of the intracellular sodium concentration ([Na]in = 10-
15 mM) and the extracellular sodium concentration ([Na]ex = 140-150 mM) and CVF is around
0.8 in normal brain tissues. Therefore TSC = CVF×[Na]in +(1-CVF)×[Na]ex. After correction of
the fractional average water content in normal brain as around 0.8, the average TSC in brain is
calculated as 45-55 mM, which is the range of values usually measured experimentally. Increas-
ing TSC is supposed to indicate loss of tissue viability while CVF indicates concomitant decrease
in cell density. TSC maps can be obtained directly from quantitative sodium MRI where reference
phantoms with known sodium concentrations and relaxation times are placed within the FOV.
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However CVF cannot be obtained directly, but can be obtained from TSC through knowledge of
[Na]in and [Na]ex, obtained from TQF sodium MRI for example [79].
Figure 3.1.1: Examples of brain images. A. Twisted projection imaging (TPI) at 3T of a healthy brain. B. Triple-
quantum filtered (TQF)-TPI at 3T of a healthy brain. C. Representative perfusion weighted imaging (PWI), diffusion
weighted imaging (DWI) at 1.5T and sodium TPI at 4.7T of the brain of a patient with acute ischemic stroke. These
images show the hypoperfused (Tmax+4s) perfusion maps, the DWI hyperintense (core) in dotted outline and the
PWI-DWI mismatch tissue (penumbra) in solid outline, and corresponding sodium images, acquired 4h and 25.5h after
symptom onset. Figures A and B: Courtesy of Professor F. Boada, New York University Medical Center / University of
Pittsburgh Medical Center. Figure C from Tsang A. et al. Journal of Magnetic Resonance Imaging 33:41 47, 2011.
Reproduced by permission of Wiley-Blackwell.
Strokes
Stroke is the third largest cause of death in the USA and a leading cause of long-term disability.
Stroke can be classified in two subtypes: ischemic and hemorrhagic. Most of the strokes are
ischemic (around 87 %). It is very important to intervene as early as possible after symptom
onset in order to reperfuse viable tissues and minimize tissue loss in order to improve recovery.
The usual treatment is trombolysis by intravenous injection of recombinant tissue plasmogen
(tPA) within a 3-hour window after onset [80], which induce recanalization of blocked arteries
and potentially reperfusion of ischemic tissues. However, there is a risk also of hemorrhagic
transformation or edema formation due to reperfusion in non-viable tissues which can reverse
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the expected outcome of trombolysis. It is therefore important to assess the viability of tissues
and their likelihood to recover before treatment is applied.
A combination of proton diffusion weighted imaging (DWI) and perfusion weighted imaging
(PWI) [81] has been proposed to help identify patients with more probable improvement in out-
come after trombolysis: ADC maps from DWI can identify regions of cerebral ischemia (water
restriction) within minutes after ischemic onset, reflecting cytotoxic edema, and PWI can detect
regions with perfusion deficits (regions at risk) within seconds of the ischemic onset. It has been
proposed that the mismatch area between a larger abnormal PWI region and a smaller lesion
in ADC map can represent the ischemic penumbra, where the tissue is at risk for infarction but
still viable, and therefore could be saved [82–84]. However, this PWI-DWI mismatch method has
some serious limitations. It has been found that DWI does not necessarily represent ischemic
tissue damage, that the limit of salvageable tissue is not limited to the volume of DWI-PWI mis-
match, and that PWI and DWI do not provide information on the duration of the acute period of
ischemia, and cannot establish the time of symptom onset, therefore unknown-onset patients are
excluded from trombolysis treatment [85,86].
A more direct method, such as quantitative sodium MRI, that could give accurate spatial
information on the tissue viability and also time information about the stroke onset would prove to
be very useful for stoke management. TSC is very sensitive to cell homeostasis and any loss of
cellular energy production will impair the Na+/K+-ATPase and induce loss of ion balance across
the cell membrane. An increase in TSC can be associated to increase of intracellular sodium due
to the loss of integrity of the cell, and also increase of extracellular volume when cells are dying.
Studies in animal model and humans have shown that sodium MRI can measure increases in
TSC over the first few hours and days after induction of cerebral ischemia, and that sodium MRI
could have a potential utility for stroke management [85–89]. These studies have shown that a
elevation of 50% in TSC above the TSC value in the homologous region in contralateral brain
hemisphere was consistent with completed infarction, which corresponds to a value of 70 mM
in humans. This value could therefore serve as a threshold for tissue viability and help decision
making about which treatment should be more adapted for the patient. It is also suggested that
the different rates of loss of tissue viability are reflected in the different rates of change in TSC
values between cortex and basal ganglia. Therefore, clinical decisions to use thrombolytic agents
may use different time windows depending on the location of the stroke. These studies showed
that sodium MRI can be used as a useful complement to DWI and PWI for managing patients with
acute and subacute stroke and that TSC evolution can help guide trombolysis protocol outside
the 3-hour time window currently used for treatment decision making.
Some examples of sodium images in human stroke are shown in Fig. 3.1.1 C. In this study,
Tsang et al. [85] showed that sodium signal intensity cannot be predicted by PWI and that is was
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not altered within the PWI-DWI mismatch tissue, irrespective of the interval between symptom
onset and image acquisition, indicating preserved viable tissue in this region. A combination of
DWI, PWI and sodium MRI could therefore provide useful information on tissue viability in patients
with stroke, and thus despite unknown symptom onset time. Further studies are necessary to
validate all these findings, with optimized sodium acquisitions with maybe TQF or IR preparation
for increasing the weighting of the images towards intracellular sodium content, but sodium MRI
seems to be very promising for helping stroke management in a quantitative and non-invasive
manner.
Tumors
Tumor malignancy can be characterized by angiogenesis and cell proliferation [90], among other
characteristics. Unregulated cell division, leading to tumor growth, can be initiated by changes
in Na+/H+ exchange kinetics and therefore changes in the intracellular and extracellular pH
[91]. This mechanism, associated with reduced Na+/K+-ATPase activity [92] leads to increased
intracellular sodium concentration that can therefore also be associated with tumor malignancy
[93, 94]. Most likely, the increase in total sodium concentration in malignant tumors depends
on both changes in extracellular volume fraction and in intracellular sodium content. Similarly,
tumor neovascularization and increase in interstitial space both lead to increased extracellular
volume fraction and are also associated with the potential for tumor proliferation [95]. Overall,
total sodium concentration levels in malignant tumors are likely to be elevated, and therefore
could maybe measured by quantitative SQ sodium MRI non-invasively. Implementing TQF or IR
in the sodium acquisition could also provide some information more specific to changes in the
intracellular sodium content by reducing the weight of fluids (from edema) and/or extracellular
sodium in the contrast of the images.
The conventional MRI protocol for brain tumor is based on T2 weighted images and T1
weighted images with and without gadolinium enhancement for detecting the location and dimen-
sion of the tumor, DWI for detecting the extent of vasogenic edema while excluding cytotoxic
edema and PWI for detecting the regions of the tumor with high vascularity on the relative cere-
bral blood volume map, which are consistent with high-grade tumor [78]. But all these changes
are generally late events in tumor onset. Adding sodium MRI to the protocol would therefore
provide direct and more rapid biochemical information on the tumor metabolism, and also help
monitor the immediate effects and follow up affects over time of cancer therapies.
Ouwerkerk et al. [94] combined proton and sodium MRI at 1.5T to measure the TSC in brain
and determine how TSC is altered in malignant tumors. Sodium images were acquired with a UTE
TPI sequence. Mean TSC (in mmol /kg wet weight) was measured as 60 for grey matter (GM), 70
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for white matter (WM), 135 for cerebrospinal fluid (CSF), 115 for vitreous humor, 100 for tumor,
70 for unaffected contralateral tissue, and 100 for regions surrounding the tumors (detected with
FLAIR hyperintense proton image). Significant differences in TSC were demonstrated for both tu-
mors and surrounding FLAIR hyperintense tissues versus GM, WM, CSF, and contralateral brain
tissue. This work shows that UTE sodium MRI can be used to quantify absolute TSC in patients
with brain tumors and shows increased sodium concentration of 50-60% in tumors relative to that
in normal brain regions. However, these measurements cannot define if TSC increases are due
to changes in extracellular volume, intracellular sodium content or neovascularization.
Figure 3.1.2: Examples of brain images. A-F: Proton and sodium images from a patient with glioblastoma (WHO
grade IV) of the left medial frontal lobe. G-L. Images and tissue sodium concentrations (TSC) from a patient with
multiple sclerosis (MS). A. T1 weighted MRI, B. T1 weighted MRI with contrast medium (rim enhancement), C. T2
weighted MRI showing cystic and solid portions of the lesion and perifocal brain edema, D. DWI showing elevated
ADC values in the center of the tumor, E. sodium MRI showing increased sodium signal in the tumor, F. sodium MRI
with fluid suppression by inversion recovery (IR), also showing increased sodium signal mainly at the center of the
tumor. Proton images (A-D) were acquired at 3T while sodium images (E, F) were acquired at 7T. G. proton density
MRI, H. T1 weighted MRI, I. sodium MRI, J. corresponding TSC map. K. box-plot of the mean TSC value distribution in
regions of white matter and grey matter in healthy controls. L. box-plot of the mean TSC value distribution in regions of
the corresponding normal appearing white matter (NAWM) and normal appearing grey matter (NAGM) in patients with
relapsing-remitting MS. Abbreviation: cc is corpus callosum. Figures A-F from Nagel A. et al. Investigative Radiology
46(9), 539-547, 2011. Reproduced by permission of Wolters Kluwer Health. Figures G-L from Inglese M. et al. Brain
133, 847-857, 2010. Reproduced by permission of Oxford University Press.
Nagel et al. [77] recently applied sodium MRI with and without IR to 16 patients with brain
tumors of different grades (WHO grades I-IV) at 7T. Some examples of proton and sodium im-
ages are presented in Fig 3.1.2 A-F. Their findings were that TSC imaging revealed increased
signal intensities in 15 of 16 brain tumors before therapy and that IR imaging enabled further
differentiation of these lesions by suppressing CSF and edema signal; all glioblastomas (grade
IV) demonstrated higher IR sodium signal intensities as compared with WHO grade I-III tumors.
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It was also noted that contrarily to total TSC signal, the IR sodium signal correlated with the his-
tologic MIB-1 proliferation rate of the tumor cells. This study shows that a combination of sodium
MRI with and without T1 relaxation weighting through IR can reveal important physiological tissue
characteristics and help characterize and grade tumors.
Very recently Fiege et al. [75] combined SQ and TQF sodium imaging in a single acquisition
scheme and applied this new sequence to 6 healthy brains and 3 brains with tumors at 4T. In this
very preliminary work, they detected a decrease of signal in tumor regions on the TQF images
compared to normal tissue, probably due to suppression of edema around the tumors. But due
to the very low resolution of the images (10 mm isotropic) and low SNR of the TQF images, it is
hard to reach any definitive conclusion yet.
Multiple Sclerosis
Another interesting application of sodium MRI in the brain would be for assessing multiple scle-
rosis (MS). MS is an inflammatory neurological disease characterized by focal and diffuse in-
flammation in white matter (WM) and grey matter (GM), by demyelination of the axons and by
neuro-axonal injury and loss, but the cellular and molecular mechanisms contributing to neurode-
generation are still poorly understood [96]. Studies have shown that the accumulation of sodium
in axons through non-inactivating sodium channels can promote reverse action of the Na+/Ca2+
exchanger, which leads to a metabolic cascade, and results in an overload of intra-axonal calcium
and axon degeneration [97,98].
Inglese et al. [99] recently demonstrated the first application of sodium MRI to MS at 3T in 17
patients with relapsing-remitting MS (rrMS) and 13 normal subjects. The main results are shown
in Fig. 3.1.2 G-H. Images were acquired at 3T with a 3D radial sequence and a birdcage coil. The
absolute TSC was measured in lesions and in several areas of normal-appearing white and grey
matter in patients (NAWM and NAGM in proton MRI), and corresponding areas of white and grey
matter in controls. Mean sodium concentrations were 20 and 30 mM in WM and GM in controls,
and 27 and 36 mM in corresponding NAWM and NAGM in MS patients. In this preliminary study,
TSC in MS patients issue were therefore elevated in acute and chronic lesions compared to areas
of NAWM. The TSC in areas of NAWM were significantly higher than those in corresponding WM
regions in healthy controls. TSC averaged over lesions and over regions of NAWM and NAGM
matter was positively associated with T2-weighted and T1-weighted lesion volumes from proton
MRI. The expanded disability status scale score showed a mild, positive association with the
mean TSC in chronic lesions, in regions of NAWM and NAGM. More studies need to be performed
to understand the pathophysiological mechanisms involved in tissue injury in MS and their link
to sodium images. Separation of intracellular and extracellular sodium by TQF [79] or IR could
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prove to be useful for this purpose. But this work shows that abnormal values of TSC measured
non-invasively with sodium MRI in patients with rrMS might reflect changes in the composition of
the lesions and/or changes in metabolic integrity.
Another recent study by Zaaraoui et al. [100] expanded the method to patients with early
and advanced rrMS. It was found that TSC increased inside demyelinated lesions in both groups
of patients. TSC was also increased in NAMW and NAGM of advanced rrMS patients, but not in
early rrMS.
Alzheimer’s Disease
Finding biomarkers for detecting early signs of AD and tracking response to treatments is a
subject of intense research. Methods such as sampling the cerebro-spinal fluid (CSF) for bio-
chemical analysis of biomarkers, positron emission tomography (PET), and MR imaging (through
regional volumetric analysis) or spectroscopy (N-acetylaspartate with 1H NMR or glutamate with
13C NMR) have been proposed.
A first study on the applicability of sodium MRI to Alzheimer’s disease (AD) was performed
by Mellon et al. [101]. The hypothesis here is that alterations of the sodium levels in brain due
to cell death or loss of viability characteristics of AD could be measured with sodium MRI non-
invasively and give useful complementary information for assessment of early AD. They did not
quantify the sodium concentrations but still were able to detect a small increase (7.5%) of the
sodium relative signal intensity in the brains of patients with AD compared to controls and found
that this signal intensity enhancement was moderately inversively correlated with hippocampal
volume measured from T1 weighted inversion recovery proton images. No conclusive explana-
tion on a physiological basis can be advanced for explaining this sodium content increase. Is it
due to increase of extracellular volume due to cell death and fluid invasion, increase of intracel-
lular sodium due to an impairment of Na+/K+-ATPase, leakage of sodium due to amyloid beta
channels in the membrane, or probably a combination of many of these causes? More studies
that allow fluid suppression and/or intracellular sodium isolation (IR, TQF) should be performed
in order to selectively study these possible aspects of AD progression.
Huntington’s Disease
A very recent preliminary study [102] showed that patients with Huntington’s disease (n=13)
also present an increased of TSC in the whole brain compared to healthy controls (n=13), in
structurally affected regions of the brain, but also in some non-affected regions. As for the AD
study, no satisfying explanation to these TSC increases could be proposed due to the limited data,
low resolution and lack of differentiation between intracellular and extracellular sodium content.
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But further more complete studies may help explain these observed TSC variations which are
generally linked to changes in cellular and metabolic integrity leading to structural degeneration.
3.2 Breast
Treatments for breast cancer such as prophylactic mastectomy or chemoprevention are more
effective when the disease is detected at an early stage. The most common techniques for
detecting breast cancer are clinical breast exam (CBE), ultrasound and x-ray mammography.
Mammography has a high sensitivity (70-90%) but a limited specificity (32-64%) leading to many
false positives, and very often cannot distinguish benign from malignant tumors [103]. Moreover,
approximately 10% of tumors are not detected by mammography due to the presence of dense fi-
broglandular tissue. Adding ultrasonography to mammography can help increasing the sensitivity
but also increases the number of false positives [104].
Proton MRI, particularly contrast-enhanced and diffusion MRI, is a promising technique for
detecting and characterizing tumors not visible in mammograms, mainly in dense tissues, as
MRI has a very high negative predictive value (rule out the presence of cancer) [105]. But the
specificity of proton MRI could be improved by adding more information about the physiology
and metabolism of suspicious lesions, such as cellular integrity and energy metabolism. As pro-
liferating tumors may cause increases in the sodium content of tissues due to disruption of the
sodium-potassium pump in cell membranes, quantitative sodium MRI would be a good candi-
date to detect tumors in the breast and also assess the degree of malignancy and follow-up
chemotherapy. To test this hypothesis, Ouwerkerk et al. [106] applied quantitative sodium MRI at
1.5T and TPI acquisition to patients with benign and malignant breast tumors before biopsy. T2
and T1 weighted contrast-enhanced proton MRI were also acquired. Sodium and proton images
were co-registered to allow quantification of TSC in normal and suspicious tissues based on 1H
MRI contrast enhancement, with histology confirmed by biopsy. The measured TSC were higher
by an average of 60% in histologically proven malignant lesions compared to glandular tissue.
TSC in benign tumors was significantly higher than adipose tissue but on the same level than
glandular tissue (34 mM). An example of these results in shown in Fig. 3.2.1.
Increased TSC can arise from increase of extracellular volume fraction (EVF) due to changes
in cellular organization, from increase of vascular volume, or from increases in the intracellular
sodium concentration due to impaired energy metabolism in Na+/K+-ATPase activity, or a com-
bination of all these causes. It is therefore impossible from this data to reach any conclusion
about the measured elevated TSC, but more studies at higher field, higher resolution, with a
combination of sodium sequences allowing to increase the weight of intracellular or extracellular
sodium on the images (such as TSC or IR), combined with sensitive proton MRI techniques
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Figure 3.2.1: Examples of breast cancer images from a patient with 5.5 cm in-
filtrating poorly differentiated ductal carcinoma (T3) at the 12 o’clock position in
the left breast. A. Fat suppressed T2 weighted MRI showing a mass with T2 in-
termediate signal and edematous T2 bright retroareolar glandular tissue (arrow).
B. Fat suppressed T1 weighted MRI post-Gd injection with contour levels in yel-
low, showing enhancement of the mass at 12 o’clock but not in the retroareolar
glandular tissue. C. Sodium MRI with contours from B superimposed in blue.
Region with edema is indicated by the green arrow. From Ouwerkerk R. et al.
Breast Cancer Res Treat DOI 10.1007/s10549-006-9485-4, 2007. Reproduced
by permission of Springer Science and Business Media.
such as DWI or T1 contrast enhanced, may al-
low to increase the sensitivity and specificity of
MRI in detecting and assessing biochemical in-
formation in breast cancer.
A multiparametric multinuclear combination
of MRI techniques could prove to be useful for
grading benign and malignant tumors, and also
for monitoring chemotherapy response [107]. It
was even shown by Jacobs et al. [108] that a
multimodal combination of 1H+23Na MRI with
computed tomography (CT) and proton emission
tomography (PET) was feasible and may help to
evaluate the complex tumor micro-environment
by examining changes in morphology, sodium
concentrations and glucose metabolism in re-
sponse therapy.
3.3 Heart
Acute myocardial infarction (MI) can lead to an increase in the intracellular sodium concentration
due to loss of ionic homeostasis, and to enlarged extracellular volume due to myocardial edema
formation or due to scar formation [109, 110]. Quantitative sodium MRI seems therefore a good
candidate to try to detect cardiac infarction by measuring localized increased sodium content in
cardiac tissues and help differentiate viable from non-viable tissues. Some preliminaries studies
using surface coils were performed over the years to test the feasibility of cardiac sodium MRI
and to try to assess infarction [47,111–114].
Ouwerkerk et al. [112] measured the myocardial TSC of healthy volunteers. Mean TSC was
approximately 43 mM in the left ventricular (LV) free wall, 53 mM in the septum and 17 mM in
adipose tissue. The same team then applied the method to twenty patients with nonacute MI.
Mean TSC for MI was measured as 30% higher than noninfarcted tissues in LV regions (signifi-
cant difference). The mean TSC in regions adjacent to MI regions was intermediate between MI
and normal tissue sodium content. They also conclude that TSC increase is not related to infarct
age, size or global ventricular function. The measured sodium TSC or pixel intensity changes
may be attributable to loss of cellular integrity, inhibition of the Na+/K+-ATPase function due to
energy depletion and changes in the sodium concentration gradient between intracellular and
extracellular volumes, and also possibly changes in the sodium ion molecular environment, and
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probably a combination of all.
Because of the methods used until now, it is difficult to find in which proportion and when
these probable physiological changes can be associated with observable changes in sodium
content or relaxation. Future studies might include imaging at higher fields for increasing the
SNR and spatial resolution for better identification of infarcted tissues and adjacent areas, and
sequences that could separate intracellular from extracellular sodium and/or relaxation times
weighted (TPI associated with TQF or IR), for a better estimation of intracellular TSC, which is
generally supposed to be more sensitive to cell energy impairment and viability.
3.4 Muscle
Sodium MRI has the potential to provide insights into muscle physiology and for assessing muscle
diseases. In muscle tissues, the electrochemical gradient across the cell membrane is maintained
by the Na+/K+-ATPase, but when an action potential leading to muscle contraction is generated,
there is a rapid influx of sodium ions and efflux of potassium ions via the sodium and potassium
channels. During intense contractile activity, the persistent influx and efflux of ions, which de-
grades the transmembrane Na+ and K+ gradients, can lead to a loss of membrane excitability
and muscle contractility [115], which is believed to represent one of the main mechanisms of
muscle fatigue [116].
It has already been shown that many disease states, such as diabetes, starvation and hy-
pothyroidism, can be linked to a decrease in Na+/K+-ATPase activity in skeletal muscle [115].
Therefore sodium MRI has the potential to play a role in imaging of these disorders. For example,
Bansal et al. [117] studied the change of sodium concentration and relaxation in muscle after
voluntary muscle contractions. They showed that the sodium intensity in the images increased
by around 34% in the exercised muscle and then diminished with a half-time of 30 min, but that
the calculated sodium concentration did not change significantly, while the long T2 component
of the sodium relaxation increased. They therefore suggest that the change in intensity in the
sodium images was mainly due to a change in the sodium-macromolecules interaction rather
than a change in TSC. We present in the following paragraphs a few examples of studies of
sodium MRI for different muscular diseases.
Diabetes
Sodium MRI has been applied recently on diabetic patients. Some results from the study by
Chang et al. [118] are presented in Fig. 3.4.1. Pre- and post-exercise sodium intensity (SI)
was measured in sodium images in healthy volunteers and patients with diabetes, in the tibialis
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anterior (TA) as control muscle, in soleus (S) and in gastrocnemius (G) muscles. It was found that
the muscle sodium signal intensities (in S and G) increase significantly immediately after exercise
and that afterwards this sodium signal recovers down to baseline more slowly in diabetics than in
healthy subjects.
Figure 3.4.1: Example of sodium images in the muscle at rest (A) and post-
exercise (B). 3D FLASH proton MRI (C) was performed after the sodium MRI to
delineate muscle anatomy: TA is tibialis anterior, S is soleus and G is gastrocne-
mius. In healthy subjects (D), sodium signal intensity increases significantly in S
and G just after exercice, but not in the control muscle TA. The sodium intensity
then decreases to near baseline in both S and G with a half-time of around 22
min. In diabetics subjects (E), sodium signal intensity increases significantly in S
and G just after exercice, but not in the control muscle TA. The sodium intensity
then decreases to near baseline half-times of around 37 min in S and 27 min in
G. From Chang G. et al. European Radiology, DOI 10.1007/s00330-010-1761-3,
2010. Reproduced by permission of Springer Science and Business Media.
The authors suggest that the biophysical
basis for the increase in sodium signal intensity
in muscle after exercise is probably multifactorial
and could be due mainly to 2 main factors: (1)
an increase in total muscle sodium content due
to increase in volumes of the intracellular and
extracellular compartments after exercise and to
the increase of intracellular concentration mus-
cle cell depolarization, therefore, the increase in
sodium signal intensity following exercise could
reflect changes in the quantity of sodium in both
compartments; (2) alterations in sodium macro-
molecular environment and therefore changes in
T2 relaxation times or in the proportions of the
long and short T2 components. One possible
explanation might be the decreased Na+/K+-
ATPase activity as well as the altered tissue
microvasculature in diabetics. Na+/K+-ATPase
preserves the muscle membrane excitability by
maintaining the Na+ and K+ concentration gra-
dients across the cell membrane and therefore
helps protect muscles against fatigue [115]. However, diabetics have a decreased Na+/K+-
ATPase activity and decreased numbers of Na+ and K+ pumps on the muscle cell membrane,
which has been attributed to insulin resistance [119]. This would result in a decreased ability to
extrude intracellular sodium ions into the extracellular space and result in elevated muscle sodium
intracellular content with a slower recovery to baseline.
This preliminary study shows that sodium MRI could therefore be applied to patients with
diabetes in order to evaluate those who are at risk of diabetic muscle infarction, which is a grave
complication of longstanding diabetes. Moreover, fluid and/or extracellular sodium suppression
by TQF or IR, along with T2 relaxation measurements, could prove to be useful to assess the
origin of the SI decrease observed in this study.
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Muscular Channelopathy
Patients with hypokalemic periodic paralysis (hypoPP) or paramyotonia congenita (PC), two dif-
ferent kinds of muscular channelopathies, were scanned with sodium MRI in a study by Nagel et
al. [120]. These rare diseases are considered to be caused by genetic mutations of the voltage-
gated sodium channels in muscular cells, and that can be characterized by elevated myoplasmic
sodium at rest and after cooling (for provocating PC pathology effects).
Three sodium techniques were used to assess the disease: total tissue sodium concentration
(23Na-TSC), T1 weighted sodium imaging (23Na-T1) and inversion recovery (23Na-IR) which was
used to suppress most of the extracellular and vascular sodium and vasogenic edema. All 23Na
sequences showed significantly higher signal intensities in hypoPP compared with PC patients
and healthy subjects, and provocation in PC induced a significant increase (>20%) in the 23Na-
IR signal and a corresponding decrease of muscle strength. Signal intensities from 23Na-T1
and 23Na-TSC also have a non-significant tendency to be higher after provocation in PC. This
study indicates that 23Na-IR could provide a stronger weighting toward intracellular sodium than
23Na-T1 or 23Na-TSC, and therefore may allow a better visualization of changes in intracellular
sodium content. A combined application of 23Na-TSC and 23Na-IR could therefore improve the
analysis of pathophysiological changes in muscles of patients with muscular channelopathies by
measuring the changes in intracellular concentration and T1 relaxation time.
The same kind of study was also performed on patient with hyperkalemic periodic paralysis
(hyperPP) by Armateifo et al. [121]. They showed that sodium MRI can detect increased my-
oplasmic sodium content in HyperPP patients with permanent weakness, as they are affected
by an incomplete inactivation of muscular sodium channels [122]. In this case too, 23Na-IR is
more sensitive to intracellular changes than 23Na-TSC and 23Na-T1. In conclusion, sodium over-
load may cause muscle degeneration developing with age and sodium MRI could therefore help
monitoring medical treatments that reduce this overload.
Myotionic Dystrophy
Myotonic dystrophy has been linked to alterations in sodium channel conductance regulation,
which can cause elevated muscle fiber concentrations that correlate with disease severity [123].
Constantinides et al. [124] have found in their study that the mean TSC measured with
sodium MRI after exercise were elevated by 16% and 22% in two healthy volunteers, and 47%
and 70% in two dystrophic muscles in compared with those at normal resting levels. These
results in patients with myotonic dystrophy are consistent with the known imbalance in sodium
homeostasis in dystrophic muscle fibers [125]. Quantitative sodium imaging could be a valuable
tool for characterizing the early onset, pathogenesis, and monitoring of pharmacologic treatment
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of dystrophic muscle, but more data need to be acquired to confirm these findings.
Hypertension
Another interesting possible application of quantitative sodium MRI in muscle is to measure the
increase of body sodium content due to hypertension, which is linked to a disturbed total body
sodium regulation.
Kopp et al. [126] measured sodium content in triceps surea of healthy volunteers and of
patients with primary aldosteronism, before and after treatment. They found a 29% increase in
muscle Na+ content in patients with aldosteronism compared with normal women and men. This
tissue Na+ content was then reduced to normal levels (20-25 mM) after successful treatment
without accompanying weight loss. They suggest that sites such as muscle (and also skin) could
serve to store Na+ nonosmotically by binding of the Na+ ion to proteoglycans within the extra-
cellular compartment without apparent accompanying fluid retention or changes in serum Na+
concentration in patients with primary aldosteronism.
Sodium MRI in muscle may therefore be useful for detecting and follow up treatment of
hypertension and also help testing the role of Na+ for assessing long-term cardiovascular risk in
populations.
3.5 Cartilage
Cartilage is a dense connective tissue that can be found in many parts of the body such as
articular joints between bones (hyaline cartilage), in the ear and nose (elastic cartilage) or in
intervertebral disk (fibrocartilage).
In this review article we will mainly focus on articular hyaline cartilage, which consists of
a small population of chondrocytes (5% of volume) within a large extracellular matrix (ECM)
made of type II collagen fibers (15 20% of the volume), proteoglycans (PG; 3 10%) and wa-
ter (65 80%) and does not contain blood vessels. PGs further consist of a protein core and
negatively charged glycosaminoglycan (GAG) side chains, which endow the cartilage with a neg-
ative fixed charge density (FCD). This FCD attracts free-floating positive counter-ions, such as
sodium 23Na+, which in turn attract water molecules within the cartilage through osmotic pres-
sure. Therefore, we can notice that unlike most of biological tissues, sodium ions in cartilage
are mostly present in the extracellular volume. The negative charge from the GAG side chains
also provides a strong electrostatic repulsive force between the PG molecules and is responsible
for the compressive stiffness of cartilage. The collagen fibers serve to immobilize the PG and
provide a tensile force opposing the tendency of the PG to expand the cartilage. Thanks to these
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properties, articular cartilage can provide synovial joints with lubrication and also serve to ab-
sorb mechanical shocks and to distribute load over the underlying bone, and thus makes normal
motion of possible [27,127].
Osteoarthritis
Osteoarthritis (OA) is the most common form of arthritis in synovial joints and a leading cause of
chronic disability, mainly in the elderly population. From the biochemical point of view, OA is a de-
generative disease of the articular cartilage mainly characterized by a reduction of FCD (or GAG)
concentration, possible changes of size and organization of the collagen fibers, aggregation of
the PG and increased water content. These changes lead to an alteration of the mechanical prop-
erties of the cartilage, which can therefore lose its load- and shear-bearing functions. At present,
there is neither a known cure nor a preventive treatment for OA, and present treatments focus
mainly on pain management with analgesics and improvement in quality of life (e.g., exercise
and weight loss). If these methods are ineffective, joint replacement surgery may be considered.
Early detection of OA, prior to irreversible morphological changes, and an accurate method for
quantifying the effects of potential treatments are therefore of fundamental importance.
Figure 3.5.1: Cartilage sodium concentration maps
from a healthy volunteer (control) and a patient with
osteoarthritis (OA). Images were acquired with 3D
radial (R3D) and IR WURST (IRW). IR WURST was
used to suppress fluids through inversion recovery
(IR) with an adiabatic WURST pulse in order to in-
crease the sensitivity of the method to change of
sodium concentration within the cartilage only. MED
= femoro-tibial medial and LAT = femoro-tibial lateral
cartilage.
Radiography is the standard method used to detect gross loss of
cartilage by measuring narrowing of the distance between the two adja-
cent bones of a joint, but does not image cartilage directly. Proton MRI,
such as T1-weighted, T2-weighted and proton density, can provide mor-
phological information on damage of cartilage, such as fissuring and
partial- or full-thickness cartilage defects, but does not give any informa-
tion on the GAG content within the ECM or the structure of the collagen
fibers network. New methods for functional proton MRI of the cartilage
are under now development, such as T1ρ mapping [128], T2 mapping
[129], GAG chemical exchange saturation transfer (gagCEST) [130],
delayed gadolinium enhanced MRI of cartilage (dGEMRIC) [131] and
diffusion weighted imaging (DWI) [132]. T2 mapping and DWI can give
information about the collagen fibers and water mobility, while the other
methods can give some information about the FCD or GAG content, in-
directly through the use of a contrast agent (dGEMRIC), or directly (T1ρ
mapping, gagCEST). All these methods are still under investigation for
assessing their specificities and sensitivities for detecting early OA.
It has been shown that sodium concentration has a strong correla-
tion with FCD and GAG content in cartilage [133], therefore quantitative
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sodium MRI could also be useful for detecting directly loss of GAG in early OA [134–136]. Sev-
eral studies have already been performed on healthy and OA cartilage, and show that in general
TSC in healthy cartilage is in the range 250-350 mM, while <250 mM in OA cartilage [136].
Because of the low resolution of the sodium images (>3 mm), due to the presence of synovial
fluid or joint effusion and also possible cartilage thickening, the sensitivity of the method to mea-
sure small changes of TSC within the cartilage only should include fluid suppression by either
TQF [137] [17,137] or IR [39,138].
An example of quantitative sodium MRI of cartilage at 7T in presented in Fig. 3.5.1, where
fluid suppression was obtained by IR with an adiabatic inversion pulse [39]. Images were ac-
quired with a 3D radial sequence. It is shown that fluid suppression allows a better differentiation
between control and OA patient. This work is still preliminary but it is reproducible and repeat-
able [139]. Another possible application under investigation would be the measurements of the
relaxation times of sodium in cartilage, which are expected to be very sensitive to any change
of their environment, such has GAG depletion of collagen fibers rupture. Some reviews on the
potential of sodium MRI and OA are presented in Ref. [27,140].
Cartilage Repair
Sodium MRI could also prove to be useful for assessing cartilage repair. Trattnig et al. [141]
showed the feasibility of dGEMRIC and sodium MRI at 7T for differentiating repaired tissue after
matrix-associated autologous chondrocyte transplantation (MACT) from native cartilage at 3T. A
strong correlation was found between sodium imaging and dGEMRIC in patients after MACT.
Another recent study by Chang et al. [142] showed that the method for assessing sodium con-
centration in cartilage repair can be improved by fluid suppression by IR.
Intervertebral Disk
Insko et al. [143] demonstrated the feasibility of sodium MRI of the intervertebral disk (IVD) in
vivo at 4T using a surface coil and 3D gradient echo sequence. This technique could be used to
measure the proteoglycan content in fibrocartilage and help detect early degenerative changes
in IVD. In a subsequent recent study, Wang et al. [144], showed that sodium MRI can correlate
with loss of proteoglycans in the spine.
3.6 Abdomen
Quantitative sodium MRI could also prove to be useful for assessing cell viability in abdominal or-
gans and in order to detect and diagnose diseases in liver, gallbladder, pancreas, kidney, spleen,
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prostate, uterus or other organs [145]. Very few studies have been performed for the moment
on the abdomen, mainly due to the lack of availability of body sodium coils and the necessity
for the acquisition sequences to take into account the cardiac and respiratoty movements of the
body, which can seriously perturb the quality of the images. However, some preliminary work is
presented here on kidney, prostate and uterus.
Kidney
The kidney is essential in regulating homeostatic functions in the body such as extracellular fluid
volume, acid-base balance (pH), electrolyte concentrations, and blood pressure (via maintaining
salt and water balance). This role depends tightly on the regulation of extracellular sodium in
the kidney, which builds up a concentration gradient from the cortex to the medulla. Thus renal
function is tightly dependent on this corticomedullary gradient and mapping this gradient with
sodium MRI could help assess kidney impairments.
Figure 3.6.1: Examples of kidney images. A. Scheme of a human kidney. Cen-
tral coronal slices of the 3D sodium images of a human kidney under normal
conditions (B) and 12-h water deprivation (C). The sodium gradient increases
significantly by 25% after water deprivation. From Maril N. et al. Magnetic Res-
onance in Medicine 56, 1229 1234, 2006. Reproduced by permission of Wiley-
Blackwell.
A first study in human by Maril et al. [146]
presents sodium MRI of kidneys before after wa-
ter deprivation, as shown in Fig. 3.6.1. This
work was performed at 3T with a surface coil
and data was acquired with a 3D gradient echo
sequence. The results show that the sodium sig-
nal intensity increased linearly from the cortex to
each of the medullae with a mean slope of 1.6
(in arbitrary units per mm) and then decreased
toward the renal pelvis. After 12 hour water de-
privation, this gradient increased significantly by
25%. The sodium gradient change in the kidney
may reflect changes in the concentration in each
kidney compartment (cortex, medulla), but also
micro-compartments within these compartments
(intracellular, extracellular, vascular), differences in the relaxation times of sodium within the tis-
sues, or a combination of all of them.
A following study by Rosen et al. [147] performed sodium MRI at 3T on a patient with a
transplanted kidney, who was previously diagnosed with end-stage hypertensive nephropathy, to
measure the corticomedullary sodium gradient and to assess the good functioning of the new kid-
ney. The kidney was imaged 4 months after transplantation. The measured mean medulla/cortex
SNR ratio was of 1.8, and the gradient slope was 1.1 (arbitrary units / mm), which is lower than
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the gradient observed in healthy kidney in the previous study. A interpretation can be made at
this stage as the kidney was recently transplanted, resolution and SNR were low and the physiol-
ogy/biochemistry involved are not fully known. More studies need to be done of course, but these
findings are encouraging for a possible application of quantitative sodium MRI for assessing renal
functions in different diseases such as nephropathy, renal failure and kidney transplantation.
Prostate
Sodium MRI of the human prostate was recently tested in vivo at 3T [148, 149] and compared
with diffusion MRI. The prostate and its different departments were identifiable, with measured
TSC of around 60 mM in the central zone and 70 mM in the peripheral zone. This method could
be a potential radiological biomarker of prostate cancer and of treatment response.
Uterus
Uterine leiomyomata (fibroids) were investigated by diffusion weighted imaging (DWI) and quan-
titative sodium MRI by Jacobs et al. [150] at 1.5T. Uterine leiomyomata are solid masses arising
from the muscle of the uterus (myometrium) and can be associated with menstrual pain and
loss of reproductive function. The goal was to monitor the treatment of fibroids on patients that
were treated using MRI guided high-intensity focused ultrasound surgery (MRg-HIFUS). Regions
where the tissue was treated were clearly identified on both DWI and sodium images. The TSC in
normal myometrium tissue was approximately 36 mM with apparent diffusion coefficient (ADC) of
2.2 mm2/s. The TSC was 28 mM in untreated fibroids and increased to 42 mM in treated tissues
while ADC was 1.75 mm2/s in untreated fibroids and decreased to 1.3 mm2/s in treated tissues.
The mechanisms involved in the changes in ADC and TSC in treated uterine tissue is still un-
known but these changes may provide an empirical measure of the efficacy of the treatment. DWI
is sensitive to translational motion and changes in the intra- and extracellular compartments avail-
able for diffusion of water molecules and can reveal disruptions or restrictions to the movement of
these molecules within a tissue. Sodium MRI is more sensitive to the gradient of ion concentration
between the intra- and extracellular compartments, which depends on the Na+/K+-ATPase activ-
ity within the cell membrane and its energy consumption. Thermal ablation disrupts the cell mem-
brane and alters the cellular integrity and perfusion of the tissue. The ADC and sodium changes
within the diseased uterine tissue before and after treatment may therefore reflect a combina-
tion of complex changes in tissues such as modification of the water environment, disruption of
Na+/K+-ATPase function, decreased vascularization or cytotoxic edema. More data must be ac-
quired to fully understand these findings, but this preliminary study suggests that DWI (ADC map)
coupled with quantitative sodium concentrations may provide useful non-invasive biomarkers for
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Figure 3.6.2: Whole body sodium MRI of a
volunteer. From Wetterling N. et al. Phys.
Med. Biol. 57, 4555-4567, 2012. Repro-
duced by permission of IOP Publishing Ltd.
uterine leiomyomata response to therapy or to investigate malig-
nant tumors, by probing biochemical changes that can give infor-
mation beyond the usual anatomical imaging parameters.
3.7 Whole Body
Most of human parts have been scanned with sodium MRI sep-
arately for the moment, and recently a study by Wetterling et
al. [151] showed a whole body sodium MRI in vivo at 3T. A new
asymmetrical birdcage coil was used to acquired the data in 5
segments of 10 min each with a 3D radial sequence, and a nom-
inal isotropic resolution of 6 mm. The resulting composite image
of the 5 acquisitions is shown in Fig. 3.6.2. Despite the low
resolution, we can easily detect many different organs such as
the brain, the left and right ventricles of the heart, the liver, the
bladder, the spine or articular cartilage. A possible application
of whole body sodium imaging would be for example the detec-
tion and malignancy assessment of cancer with metastases, and
follow-up of the chemotherapeutic response.
3.8 Cancer and Chemotherapeutic Response
Although the following studies were not performed on humans but on rats or mice in vivo, it is
useful to mention them as they represent an important preliminary work previous to potential
human applications on cancer and chemotherapeutic response assessment [40, 152, 153]. The
goal of cancer therapy is to eliminate neoplastic cells, but assessment of the therapeutic efficiency
in vivo may be difficult. Different functional imaging modalities such as PET (rate of glycolysis),
DWI MRI (extracellular volume) or sodium MRI (intracellular sodium) could prove to be useful for
this purpose.
Chemotherapy Assessment
It has already been demonstrated that DWI can be useful for quantitative assessment of tumor
response to therapeutic insult by observing the microscopic changes in water diffusion due to
cellular destruction and that is highly sensitive to microscopic changes in cellular structure [154].
These microscopic changes generally precede macroscopic changes in tumor volume, which oc-
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cur at much later stages after therapeutic insult. On the other hand, quantitative sodium MRI can
give direct information of the intracellular and extracellular sodium concentrations, which depend
on the good function of the sodium channels and Na+/K+-ATPase in the cell membrane and
cellular energy consumption. Therefore any disruption in cellular integrity can lead to abnormal
imbalances that are detectable using sodium MRI.
Schepkin at al. [155] studied the possibility of using DWI and sodium MRI for assessing non-
invasively the effect of chemotherapeutic treatment of tumors in vivo. The study was performed
on 9L gliosarcomas implanted in rats and then treated with varying doses of BCNU. MRI were
acquired at 21.1T. Main results are shown in Fig. 3.8.1 A-B. This study demonstrate that there is a
very good correlation between DWI and sodium MRI in their ability to reveal the efficacy of tumor
therapy in a few days following treatment in a dose dependent manner. As both these methods
rely on biophysical properties driven by changes in cellular structure (though slightly different), it
was expected that they should provide similar results.
Babsky et al. [152] implanted fibrosarcoma (RIF-1) tumors in mice and monitored the ef-
fects of 5-fluorouracil (5FU) treatment with proton DWI, SQ and TQF sodium MRI and also PET
for measuring Fluorodeoxyglucose (FDG) uptake in the tumor. Tumor volumes significantly de-
creased in treated animals and slightly increased in control tumors ones 2 and 3 days post-
treatment. SQ sodium signal intensity (SI) and water ADC increased in treated tumors but not in
control tumors during the same period. TQF sodium SI and FDG uptake were significantly lower
in treated tumors compared with control tumors 3 days after 5FU treatment. They concluded
that the correlated increases in SQ sodium SI and water ADC following chemotherapy might re-
flect an increase in extracellular space, while the lower TQF sodium signal and FDG uptake in
treated tumors compared with control tumors suggest a shift in tumor metabolism from glycolysis
to oxidation and/or a decrease in cell density. A multiparametric approach using 1H+23Na MRI,
PET and histology could therefore provide a clearer understanding of the relationship between
metabolic and ionic changes in tumors caused by chemotherapies.
Kline et al. [40] used sodium MRI with IR to monitor the response to chemotherapy of mouse
xenograft tumors propagated from human prostate cancer cell lines, in order to increase the
weighting of the images toward intracellular sodium content. A 37% increase in sodium signal
intensity was observed between images before and 24h after administration of antineoplastics,
which may due to an increase of intracellular sodium in the treated tumors due. These findings
can be matched with experiments with these same drugs and cells treated in culture, where a
significant intracellular sodium elevation (10-20 mM) was detected using a ratiometric fluorescent
dye. Flow cytometry also showed that this intracellular sodium increase preceded cell death by
apoptosis. Sodium MRI with IR seems to increase the weight of the images to intracellular sodium
and could help monitoring non-invasively apoptosis of tumors cells induced by chemotherapy.
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Figure 3.8.1: Examples of sodium MRI and proton DWI studies on tumor and chemotherapeutic response in a rat
glioma. A. Sodium images (top) and proton ADC maps (bottom) of a BCNU-treated 9L rat glioma acquired at day 0,
7 and 23 (left to right) after BCNU injection, performed at day 17 after tumor implantation. Central sodium image at
day 7 show a dramatic increase of sodium concentration throughout the entire tumor area. Image at day 23 shows
tumor regrowth after tumor shrinking started at day 9 and its maximum regression at day 16. B. Correlation of tumor
sodium concentration and ADC in the rat glioma obtained at various points following a single dose of BCNU. C. Time
course after tumor implantation of sodium (left) and ADC (right) variations for a naive type 9L glioma. Sodium and ADC
data are given in percent relative to normal contralateral brain. All data are presented as mean ± standard deviation.
Sodium concentration steadily increased in the naive tumor with a rate of 2.4% per day while ADC was practically
unchanged (1.4% per day). D. Time course after tumor implantation of sodium (left) and ADC (right) variations for
a glioma created from a resistant 9L cell line. Sodium concentration steadily increased in the resistant tumor with a
rate of 5.8 % per day while ADC was practically unchanged (1.2% per day). Sodium values were corrected for partial
volume effect. Figures A and B from Schepkin V.D et al. Magnetic Resonance in Medicine 53:85 92, 2005. Figures C
and D from Schepkin V.D. et al. Magnetic Resonance in Medicine 67:1159 1166, 2012. Reproduced by permission of
Wiley-Blackwell.
Tumor Resistance to Therapy
Schepkin et al. [156] also studied the capability of sodium MRI and DWI for monitoring the tumor
resistance to chemotherapy in intracranial rat 9L gliomas, in order to see if these methods could
be used as biomarkers for drug resistance. It was first measured that implanted resistant 9L
cells created tumors with significantly reduced TSC (57 mM) than nonresistant (naive) 9L cells
(78 mM) and that corresponding differences in ADC were less pronounced but still statistically
significant.
The main results are presented in Fig. 3.8.1 C-D which shows the time course evolution of
sodium content and ADC in naive and resistant tumors after chemotherapeutic injection (BCNU).
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Both Sodium and ADC can differentiate resistant from naive tumors. It is shown that sodium con-
tent and ADC vary at very different rates in the two kinds of tumors after treatment and thus must
depends on different mechanisms. Many parameters are involved such as tumor volume change,
increased extracellular volume, increased intracellular sodium concentration due to deficit in ATP
production, increase of blood supply, lactate overproduction (indicator of increased glycolysis).
As lactate production tends to correlate with tumor aggressiveness, the increasing intracellular
sodium content could be an indicator of growing tumor malignancy. No definite answer can be
given but it seems that an increase in intracellular sodium might be the main mechanism involved
in the detected increase of sodium signal.
This study shows that TSC measured with sodium MRI could give important information
about the level of drug resistance before chemotherapy and that it is more sensitive than DWI for
detecting small changes in tumor resistance.
45

Conclusion
We have seen that sodium MRI can help assess directly, in a non-invasive and quantitative man-
ner, some important new metabolic information such as tissue viability, through cell integity and
energy status, and that this information cannot be determined by standard anatomical or func-
tional proton MRI or other non-invasive imaging modality.
From the research point of view, there is an increasing interest in this technique, as more
and more tissues and diseases are investigated, from brain tumors or strokes to osteoarthritis in
articular cartilage, passing through kidney impairments and diabetes in muscles. However, more
research still needs to be on both software and hardware for improving the data acquisitions and
reconstructions, and increasing the sensitivity of the technique to specific sodium parameters
(e.g. intracellular sodium or relaxation times).
From the medical point of view, more research still has to be performed in vivo, on more
patients with diseases (longitudinal studies) or healthy subjects (optimization of data acquisitions
and reconstruction) in order to convince radiologist/physicians that sodium MRI could add some
crucial information for the diagnosis but also prognosis of diseases, for the management of pa-
tients (e.g. with stroke) or about the possible outcomes of treatments (chemotherapy resistance).
And last but not least, from the commercial point of view, sodium MRI cannot become a clin-
ical tool without the help of the major scanner vendors which should help develop multichannel-
multinuclear hardware, new multi-tuned RF coils and new UTE sequences and reconstruction
algorithms along with the availability of high magnetic fields (>3T).
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